Back to search

Article

Synergistic Antileukemic Effects of Hydroxyurea and SRJ23 in T-cell Acute Lymphoblastic Leukemia

2024-12-19

Abstract excerpt

<title>Abstract</title> <p>Background T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive blood cancer associated with high relapse rates, affecting about 15% of pediatric and 25% of adult cases. Initial management typically involves hydroxyurea (HU) to reduce elevated white blood cell counts before intensive chemotherapy. However, despite this approach, recurrence remains a substantial challenge,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
35f3b91e-d5e5-50d4-ae8c-16566271ca19
DOI
10.21203/rs.3.rs-5419120/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergistic Antileukemic Effects of Hydroxyurea and SRJ23 in T-cell Acute Lymphoblastic LeukemiaDOI 10.21203/rs.3.rs-5419120/v1
Select a neighboring publication to make it the new centre.